title: The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with chronic renal failure.
abstract: OBJECTIVE
  This study was designed to analyze the in-hospital and six-month clinical and angiographic outcomes of patients with chronic renal failure (CRF) treated with intracoronary radiation for the prevention of recurrence of in-stent restenosis.
  
  
  BACKGROUND
  Patients with CRF are at a higher risk than the general population for accelerated atherosclerotic cardiovascular disease and for restenosis after percutaneous coronary intervention. Previous studies have shown the effectiveness of both beta and gamma radiation in preventing recurrent restenosis in patients with in-stent restenosis.
  
  
  METHODS
  We studied the in-hospital and six-month clinical and angiographic outcomes of 118 patients with CRF and 481 consecutive patients without CRF who were treated with intracoronary radiation for the prevention of recurrence of in-stent restenosis in native coronaries and saphenous vein grafts.
  
  
  RESULTS
  Patients with CRF were usually older, women, hypertensive and diabetic, with multivessel disease and with reduced left ventricular function. In-hospital outcome for patients with CRF was marred by a higher incidence of death, non-Q-wave myocardial infarction and major vascular and bleeding complications. At six-month follow-up, the mortality rate was higher in patients with CRF, 7.6% compared with 1.9% in non-CRF patients (p = 0.003). Restenosis, target lesion revascularization (TLR) and target vessel revascularization (TVR) rates were similar in the two groups. In patients with CRF, radiation therapy compared to placebo reduced restenosis (53.8% vs. 22.6%, p = 0.04), TLR (71.4% vs. 15.3%, p < 0.0001) and TVR (78.6% vs. 23.7%, p = 0.0002).
  
  
  CONCLUSIONS
  Intracoronary radiation for the prevention of recurrence of in-stent restenosis achieved similar rates of restenosis and revascularization procedures in patients with and without CRF. Despite this benefit, patients with renal dysfunction continued to have significantly higher in-hospital and six-month adverse outcomes.
authors.affiliation: Washington Hospital Center, Washington, DC 20010, USA.
authors.forename: L
authors.initials: L
authors.lastname: Gruberg
authors.forename: R
authors.initials: R
authors.lastname: Waksman
authors.forename: A E
authors.initials: AE
authors.lastname: Ajani
authors.forename: H S
authors.initials: HS
authors.lastname: Kim
authors.forename: R L
authors.initials: RL
authors.lastname: White
authors.forename: E
authors.initials: E
authors.lastname: Pinnow
authors.forename: R
authors.initials: R
authors.lastname: Deible
authors.forename: L F
authors.initials: LF
authors.lastname: Satler
authors.forename: A D
authors.initials: AD
authors.lastname: Pichard
authors.forename: K K
authors.initials: KK
authors.lastname: Kent
authors.forename: J
authors.initials: J
authors.lastname: Lindsay
mesh_terms: D000368:Aged; D001918:Brachytherapy; D017023:Coronary Angiography; D003327:Coronary Disease / Q000150:complications / Q000532:radiotherapy* / Q000628:therapy; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D055502:Secondary Prevention; D015607:Stents